{"id":264786,"date":"2026-09-23T14:20:20","date_gmt":"2026-09-23T08:50:20","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=264786"},"modified":"2026-09-23T14:20:20","modified_gmt":"2026-09-23T08:50:20","slug":"why-symbiotec-pharmalab-share-price-price-fall-2026-09-23","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/","title":{"rendered":"SYMBIOTEC PHARMALAB (SYMBIOTEC) Share Price Falls 5.69% Today"},"content":{"rendered":"<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;23 September 2026 at 2:19:03 PM IST<\/p>\n<p style=\"margin-top:0!important;\">SYMBIOTEC Share Price declined today, with the stock closing at Rs 1,057.40 versus the previous close of Rs 1,121.25. The move translates into a fall of Rs 63.85, or 5.69%, and places the company at a market capitalisation of Rs 7,443.75 Cr. In today\u2019s trade, the shares opened at Rs 1,126.10, touched an intraday high of Rs 1,130.75 and a low of Rs 1,055.70. The supplied data confirms the price event, but it does not establish a company-specific catalyst. That makes the day\u2019s move important for SYMBIOTEC Share Price Today readers who want to separate the observed decline from any unverified explanation. The stock also ended very close to the session low, which keeps attention on how selling pressure built through the day rather than on any single intraday swing.<\/p>\n<p>For investors tracking SYMBIOTEC Stock News, the focus is on what the numbers show: a Mid Cap company, a large absolute price move, and a close near the day\u2019s low. Univest is covering this as a price-action event first, then placing it in valuation and sector context so readers can judge the move in a disciplined way. The same approach also helps readers compare the session with other SYMBIOTEC Share Price updates without assuming an unverified reason behind the decline.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#SYMBIOTEC_PHARMALAB_SYMBIOTEC_Share_Price_Today_Price_Action_Analysis\" title=\"SYMBIOTEC PHARMALAB (SYMBIOTEC) Share Price Today: Price Action Analysis\">SYMBIOTEC PHARMALAB (SYMBIOTEC) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#SYMBIOTEC_PHARMALAB_SYMBIOTEC_Fundamental_Analysis\" title=\"SYMBIOTEC PHARMALAB (SYMBIOTEC) Fundamental Analysis\">SYMBIOTEC PHARMALAB (SYMBIOTEC) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#Why_Investors_Are_Watching_SYMBIOTEC\" title=\"Why Investors Are Watching SYMBIOTEC\">Why Investors Are Watching SYMBIOTEC<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#About_SYMBIOTEC\" title=\"About SYMBIOTEC\">About SYMBIOTEC<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#Track_SYMBIOTEC_Share_Price_on_Univest\" title=\"Track SYMBIOTEC Share Price on Univest\">Track SYMBIOTEC Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#Why_did_SYMBIOTEC_Share_Price_fall_today\" title=\"Why did SYMBIOTEC Share Price fall today?\">Why did SYMBIOTEC Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#What_is_the_current_SYMBIOTEC_Share_Price_Today\" title=\"What is the current SYMBIOTEC Share Price Today?\">What is the current SYMBIOTEC Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#What_does_SYMBIOTEC_market_capitalisation_show\" title=\"What does SYMBIOTEC market capitalisation show?\">What does SYMBIOTEC market capitalisation show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#How_does_SYMBIOTEC_look_on_valuation\" title=\"How does SYMBIOTEC look on valuation?\">How does SYMBIOTEC look on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-share-price-price-fall-2026-09-23\/#What_do_SYMBIOTEC_EPS_and_book_value_mean\" title=\"What do SYMBIOTEC EPS and book value mean?\">What do SYMBIOTEC EPS and book value mean?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"SYMBIOTEC_PHARMALAB_SYMBIOTEC_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>SYMBIOTEC PHARMALAB (SYMBIOTEC) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,057.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,121.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 63.85 (-5.69%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,126.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,130.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,055.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 19.7 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,443.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>SYMBIOTEC Share Price Today shows a clear one-day decline from Rs 1,121.25 to Rs 1,057.40. The stock opened at Rs 1,126.10, traded up to Rs 1,130.75 and then weakened through the session to a low of Rs 1,055.70 before ending near that level. The day\u2019s change of Rs 63.85 is the central fact in today\u2019s move, and the close remained below the opening level as well as below the previous close. Turnover stood at Rs 19.7 Cr, which is the traded value recorded for the session. Because the company is a Mid Cap name with a market capitalisation of Rs 7,443.75 Cr, the move is relevant both for short-term stock news and for broader portfolio tracking. SYMBIOTEC Share Price today therefore reflects a sharp single-session decline that needs to be read alongside valuation and sector positioning rather than through any unverified trigger. For readers following SYMBIOTEC Share Price, the important point is that the entire session stayed under pressure after the early trade, and the close did not recover the opening zone. That naturally leads into a closer look at the company\u2019s financial profile and what it implies for SYMBIOTEC Share Price analysis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"SYMBIOTEC_PHARMALAB_SYMBIOTEC_Fundamental_Analysis\"><\/span><strong>SYMBIOTEC PHARMALAB (SYMBIOTEC) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,443.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">65.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 231.19<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>SYMBIOTEC PHARMALAB has a market capitalisation of Rs 7,443.75 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 65.56x, P\/B at 4.85x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.22% and ROCE of 12.41%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 17.1, book value per share of Rs 231.19, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 31.75x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view. In this SYMBIOTEC Share Price update, the valuation gap is more useful as context than as a standalone conclusion, because the data available today only supports comparison, not attribution.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">65.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.75x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.54x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.48x to 765.12x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.34x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.65%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.46%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,443.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 748.47 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,370.3 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>SYMBIOTEC operates in the Healthcare sector and the Pharmaceuticals &#038; Drugs industry, and the supplied benchmark uses the same industry universe of 200 companies. Within that set, SYMBIOTEC\u2019s P\/E of 65.56 is above the industry median of 31.75 and also above the industry average of 49.54. Its P\/B of 4.85 is above the median of 3 but slightly above the average of 4.34. ROE at 11.22% is below the industry median of 11.7% but above the industry average of 10.65%, while ROCE at 12.41% is below both the median of 13.46% and the average of 13.26%. Market capitalisation of Rs 7,443.75 Cr is above the industry median market cap of Rs 748.47 Cr, though below the industry average of Rs 14,370.3 Cr. This sector and industry context is central to SYMBIOTEC Share Price because it shows how the stock sits in relation to the broader pharmaceuticals universe. For SYMBIOTEC Stock Analysis, the key point is that the day\u2019s decline happened in a business segment where valuation and return ratios are meaningful comparison points.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,48,195.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,50,389.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.8<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,88,966.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,15,860.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,11,888.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Peer comparison helps place SYMBIOTEC Share Price in context. Compared with Sun Pharmaceutical Industries at P\/E 36.58, P\/B 5.12, ROE 14.85% and ROCE 19.11%, SYMBIOTEC trades at a higher P\/E but a slightly lower P\/B and lower return ratios. Versus Zydus Lifesciences, which shows a P\/E of 25.66 and ROE of 19.69%, SYMBIOTEC again carries a richer earnings multiple. Cipla has a P\/E of 33.1 and ROCE of 16%, both below SYMBIOTEC\u2019s P\/E and above its ROCE in the latter case. Divi\u2019s Laboratories and Torrent Pharmaceuticals both show much higher P\/E ratios than SYMBIOTEC, but also stronger P\/B levels and better return metrics. In peer terms, SYMBIOTEC Share Price sits in a mixed zone: not the most expensive in the group, but above several large listed peers on earnings multiple, while trailing some of them on return ratios.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_SYMBIOTEC\"><\/span><strong>Why Investors Are Watching SYMBIOTEC<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>SYMBIOTEC Share Price fell 5.69% today, with the stock closing at Rs 1,057.40 after a previous close of Rs 1,121.25.<\/li>\n<li>The day\u2019s range was Rs 1,055.70 to Rs 1,130.75, with the open at Rs 1,126.10.<\/li>\n<li>Market capitalisation stands at Rs 7,443.75 Cr, placing the company in the Mid Cap category.<\/li>\n<li>The stock\u2019s P\/E is 65.56, P\/B is 4.85, ROE is 11.22% and ROCE is 12.41%.<\/li>\n<li>In the healthcare peer set, SYMBIOTEC\u2019s valuation sits above the industry median P\/E of 31.75 and the industry median P\/B of 3.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_SYMBIOTEC\"><\/span><strong>About SYMBIOTEC<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>SYMBIOTEC PHARMALAB is classified in the Healthcare sector and the Pharmaceuticals &#038; Drugs industry. The company\u2019s current market capitalisation is Rs 7,443.75 Cr, and its stock is listed under the symbol SYMBIOTEC. For readers searching SYMBIOTEC Company News, SYMBIOTEC Latest News or SYMBIOTEC Share Price Live, this article focuses on the verified market figures available today: price, valuation, returns and industry comparison. Univest is using only the supplied data to present the stock in a clean, event-led format.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_SYMBIOTEC_Share_Price_on_Univest\"><\/span><strong>Track SYMBIOTEC Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\">SYMBIOTEC PHARMALAB (SYMBIOTEC) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<p>Readers can track SYMBIOTEC Share Price on Univest for live price updates, key valuation ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together stock news, company context and benchmark comparisons in one place so users can follow SYMBIOTEC Share Price Today without switching between multiple sources.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_SYMBIOTEC_Share_Price_fall_today\"><\/span><strong>Why did SYMBIOTEC Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;SYMBIOTEC Share Price fell 5.69% today to Rs 1,057.40. The supplied data confirms the decline, but it does not establish a company-specific catalyst or reason for the move. The previous close was Rs 1,121.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_SYMBIOTEC_Share_Price_Today\"><\/span><strong>What is the current SYMBIOTEC Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The current SYMBIOTEC Share Price is Rs 1,057.40. It compares with the previous close of Rs 1,121.25, showing a day-wise fall of Rs 63.85 in today\u2019s session. The previous close was Rs 1,121.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_SYMBIOTEC_market_capitalisation_show\"><\/span><strong>What does SYMBIOTEC market capitalisation show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;SYMBIOTEC has a market capitalisation of Rs 7,443.75 Cr and is placed in the Mid Cap category. Market capitalisation indicates company size, not quality or future performance. The company operates in the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_SYMBIOTEC_look_on_valuation\"><\/span><strong>How does SYMBIOTEC look on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;SYMBIOTEC trades at a P\/E of 65.56 and a P\/B of 4.85. In the same industry benchmark, those levels sit above the median P\/E of 31.75 and median P\/B of 3.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_SYMBIOTEC_EPS_and_book_value_mean\"><\/span><strong>What do SYMBIOTEC EPS and book value mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;SYMBIOTEC EPS is Rs 17.1 and book value is Rs 231.19 per share. EPS measures earnings attributable to each share, while book value shows the accounting net worth behind each share.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SYMBIOTEC PHARMALAB Share Price falls to Rs 1,057.4. marking a 5.69% fall today. Market cap stands at Rs 7,443.75 crore.<\/p>\n","protected":false},"author":29,"featured_media":264785,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-264786","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["264785"],"rank_math_title":["SYMBIOTEC Share Price Fall in Healthcare Sector Context"],"rank_math_description":["SYMBIOTEC Share Price fell 5.69% today to Rs 1,057.40. Read the price action, fundamentals, sector benchmark and peer context."],"rank_math_focus_keyword":["SYMBIOTEC Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/symbiotec-pharmalab-symbiotec-share-price-falls-5-69-today.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/264786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=264786"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/264786\/revisions"}],"predecessor-version":[{"id":264787,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/264786\/revisions\/264787"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/264785"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=264786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=264786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=264786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}